Page last updated: 2024-09-02

kt 6149 and Bladder Cancer

kt 6149 has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jakse, G; Kaviani, S; Raffenberg, G; Rohde, D; Wolff, J	1

Other Studies

1 other study(ies) available for kt 6149 and Bladder Cancer

Article	Year
7-N-(2-([2-(gamma-L-glutamylamino)-ethyl]-dithio)-ethyl)-mitomycin C (KW-2149) is more active than mitomycin C on chemonaive and drug-resistant urothelial carcinoma cells. Urological research, 1998, Volume: 26, Issue:4 Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Drug Interactions; Drug Resistance, Neoplasm; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Tumor Cells, Cultured; Urinary Bladder Neoplasms	1998

Article

Year

7-N-(2-([2-(gamma-L-glutamylamino)-ethyl]-dithio)-ethyl)-mitomycin C (KW-2149) is more active than mitomycin C on chemonaive and drug-resistant urothelial carcinoma cells.

Urological research, 1998, Volume: 26, Issue:4

Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Drug Interactions; Drug Resistance, Neoplasm; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Tumor Cells, Cultured; Urinary Bladder Neoplasms

1998